Literature DB >> 18557594

Long-term results and quality-of-life measures in the management of hyperhidrosis.

Ibrahim B Cetindag1, Theresa M Boley, Kelli N Webb, Stephen R Hazelrigg.   

Abstract

Primary focal hyperhidrosis has a significant, negative impact on quality of life, causing impairments in social, physical, leisure, and occupational activities. The outcome of different surgical and medical treatment modalities is best assessed by using a combination of tools. Quantitative tools include gravimetry, evaporimetry, and Minor's starch and iodine test. Qualitative assessment tools include general health surveys and hyperhidrosis-specific surveys. Of these, the HDSS has been found to have a good correlation to other assessment tools and to be practical in the clinical setting. The surgical literature has primarily used qualitative tools to assess outcomes and many of these tools are investigator-developed, rather than standardized surveys, which may be partly because of the largely retrospective nature of these studies. A surgical investigator's goal tends to be focused on obtaining specific postoperative information regarding symptom improvement and potential surgical complications. The VATS can have a major positive impact on the quality of life of patients who have hyperhidrosis. The impairment that this disorder causes is often underappreciated by the medical community.

Entities:  

Mesh:

Year:  2008        PMID: 18557594     DOI: 10.1016/j.thorsurg.2008.01.009

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  8 in total

1.  [Focal hyperhidrosis.Quality of life, socioeconomic importance and use of internal medicinal therapy].

Authors:  B Rzany; C Müller; M Hund
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

2.  An epidemiological study of hyperhidrosis patients visiting the Ajou University Hospital hyperhidrosis center in Korea.

Authors:  Eun Jung Park; Kyung Ream Han; Ho Choi; Do Wan Kim; Chan Kim
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

3.  Economic evaluation of botulinum toxin versus thoracic sympathectomy for palmar hyperhidrosis: data from a real-world scenario.

Authors:  Beatriz Isla-Tejera; Juan Ruano; María A Alvarez; Teresa Brieva; Manuel Cárdenas; Carlos Baamonde; Angel Salvatierra; José-Ramón Del Prado-Llergo; José C Moreno-Giménez
Journal:  Dermatol Ther (Heidelb)       Date:  2013-05-14

Review 4.  Management of hyperhidrosis.

Authors:  Anna-Bianca Stashak; Jerry D Brewer
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-10-29

5.  The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).

Authors:  P Kamudoni; B Mueller; M S Salek
Journal:  Qual Life Res       Date:  2014-11-01       Impact factor: 4.147

6.  Hyperhidrosis: an update on prevalence and severity in the United States.

Authors:  James Doolittle; Patricia Walker; Thomas Mills; Jane Thurston
Journal:  Arch Dermatol Res       Date:  2016-10-15       Impact factor: 3.017

7.  Pulsed radiofrequency stimulation suppresses palmar hyperhidrosis in an animal study.

Authors:  Mu-Lien Lin; Tzu-Rung Huang; Ming-Chien Kao; Hung-Wei Chiu; Sheng-Chieh Lin; Fang-Chia Chang
Journal:  Brain Behav       Date:  2017-09-26       Impact factor: 2.708

8.  Hyperhidrosis Prevalence: A Disease Underreported by Patients and Underdiagnosed by Physicians.

Authors:  Surajsingh Wadhawa; Sudha Agrawal; Manoj Chaudhary; Sanjib Sharma
Journal:  Indian Dermatol Online J       Date:  2019-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.